These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27010965)

  • 1. Characteristics of NIH- and industry-sponsored head and neck cancer clinical trials.
    Devaiah A; Murchison C
    Laryngoscope; 2016 Sep; 126(9):E300-3. PubMed ID: 27010965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 473 US Head and Neck Cancer Trials (1996-2014): Trends, Gaps, and Opportunities.
    Devaiah A; Murchison C
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):309-14. PubMed ID: 26577773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.
    Turner B; Rajeshuni N; Tran EM; Ludwig CA; Tauqeer Z; Weeks B; Kinde B; Pershing S
    Am J Ophthalmol; 2020 Mar; 211():132-141. PubMed ID: 31730839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer clinical trials in the United States: Understanding trends to maximize impact.
    Hsieh A; Murchison C; Devaiah A
    Head Neck; 2019 Jul; 41(7):2346-2352. PubMed ID: 30779240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
    Roumiantseva D; Carini S; Sim I; Wagner TH
    Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with results reporting at ClinicalTrials.gov.
    Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
    N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the National Institutes of Health on radiology research.
    Itagaki MW
    Radiology; 2008 Apr; 247(1):213-9. PubMed ID: 18372469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sponsorship of oncology clinical trials in the United States according to age of eligibility.
    Neel DV; Shulman DS; Ma C; Bourgeois F; DuBois SG
    Cancer Med; 2020 Jul; 9(13):4495-4500. PubMed ID: 32351000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental treatment costs in national cancer institute-sponsored clinical trials.
    Goldman DP; Berry SH; McCabe MS; Kilgore ML; Potosky AL; Schoenbaum ML; Schonlau M; Weeks JC; Kaplan R; Escarce JJ
    JAMA; 2003 Jun; 289(22):2970-7. PubMed ID: 12799405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials.
    Riaz H; Raza S; Khan MS; Riaz IB; Krasuski RA
    Am J Cardiol; 2015 Dec; 116(12):1944-7. PubMed ID: 26611124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
    Zwierzyna M; Davies M; Hingorani AD; Hunter J
    BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
    Privitera M
    Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.
    Zhou EW; Jackson MJ; Ledley FD
    JAMA Health Forum; 2023 Jul; 4(7):e231921. PubMed ID: 37450296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data monitoring boards in the pharmaceutical industry.
    Herson J
    Stat Med; 1993 Mar; 12(5-6):555-61; discussion 563. PubMed ID: 8493431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials.
    Johnson AL; Fladie I; Anderson JM; Lewis DM; Mons BR; Vassar M
    JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):176-182. PubMed ID: 31876933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy.
    Giacalone NJ; Milani N; Rawal B; Catalano PJ; Nguyen PL; Schoenfeld JD; Tishler RB; Margalit DN
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):34-43. PubMed ID: 29970311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Impact of the NIH CTSA Program on Clinical Trials Registered With ClinicalTrials.gov.
    Berg A
    Clin Transl Sci; 2020 Jul; 13(4):818-825. PubMed ID: 32216083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.